The efficiency of dentine adhesives in treating non-caries cervical lesions.
The aim of this study was to prove the hypothesis that dentine adhesives can be used as therapeutic material in treating dentine hypersensitivity, regardless of aetiology. The research was conducted on 492 students of Zagreb University School of Dental Medicine (154 male, 338 female), 20-25-years-old. The defects of the tooth neck were found in 38 patients, on 133 teeth (38 of male patients, 95 of female) and dentine hypersensitivity was recorded according to the subjective sensations of patients. Therapeutic characteristics of three adhesive materials were examined simultaneously: All Bond 2, fourth generation adhesive, Syntac Single Component and One Step, fifth generation adhesives. Teeth treated with dentine lacquer Cervitec were used as a control group. Tooth necks were treated with selected materials according to instructions of a manufacturer. A completed statistical survey of the results has clearly shown that dentine adhesives can be used in symptomatic therapy of dentine hypersensitivity of the non-caries cervical lesions (NCCL). The survey has also shown that dentine adhesives of the fifth generation (Syntac Single Component and One Step) have much higher efficiency rate than dentine adhesives of the fourth generation (All Bond 2) and dentine lacquer (Cervitec). According to data complied through this study the conclusion can be brought forward that dentine adhesives are not a final solution to the problem of dentine hypersensitivity, because their efficiency decreases with time.
Pandurić
V
V
Department of Dental Pathology, University of Dental Medicine, Gundulićeva 5, Zagreb, Croatia. vpanduric@usa.net
Knezević
A
A
Tarle
Z
Z
Sutalo
J
J
D000328:Adult; D000704:Analysis of Variance; D002710:Chlorhexidine / Q000627:therapeutic use; D003807:Dentin Sensitivity / Q000145:classification / Q000628:therapy*; D017220:Dentin-Bonding Agents / Q000145:classification / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008689:Methacrylates / Q000627:therapeutic use; D019279:Resin Cements / Q000627:therapeutic use; D013943:Thymol / Q000627:therapeutic use; D019237:Tooth Cervix / Q000187:drug effects*; D016896:Treatment Outcome
C103506:Bis-GMA, BPDM, HEMA dental-bonding resin; D017220:Dentin-Bonding Agents; D004338:Drug Combinations; D008689:Methacrylates; D019279:Resin Cements; C078484:Syntac dentine adhesive; C079161:chlorhexidine, thymol drug combination; C100742:All-Bond 2; D013943:Thymol; D002710:Chlorhexidine